CSIMarket Company Name, Ticker, Suppliers, else..
 
Medavail Holdings Inc   (NASDAQ: MDVL)
Other Ticker:  
 
 
Price: $1.8000 $-1.23 -40.594%
Day's High: $2.54 Week Perf: -45.29 %
Day's Low: $ 1.74 30 Day Perf: -49.72 %
Volume (M): 245 52 Wk High: $ 0.00
Volume (M$): $ 441 52 Wk Avg: $0.00
Open: $2.51 52 Wk Low: $0.00



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 2
 Employees 160
 Revenues (TTM) (Millions $) 24
 Net Income (TTM) (Millions $) -46
 Cash Flow (TTM) (Millions $) -15
 Capital Exp. (TTM) (Millions $) 1

Medavail Holdings Inc
Medavail Holdings Inc. is a technology-enabled pharmacy company that offers on-site prescription dispensing and virtual consultations through its kiosks and telemedicine platform. The company is headquartered in Mississauga, Ontario, Canada, and was founded in 201

Medavail's pharmacy kiosks are placed in high-traffic areas such as university campuses, workplaces, and retail stores. The kiosks are designed to dispense medication 24/7 without the need for a pharmacist on-site. Customers can request prescription refills, receive medication consultations, and speak with a licensed pharmacist through the kiosk's video conferencing capabilities.

Medavail's telemedicine platform enables customers to connect with licensed pharmacists through video and phone consultations. Customers can also access medication recommendations, lab testing, and health monitoring through the platform.

The company's technology platform seamlessly integrates with electronic medical records, allowing healthcare providers to offer on-site medication dispensing at their clinics. Medavail's services are currently available in several Canadian provinces and select U.S. states.

Medavail has partnerships with several insurance providers, employers, and healthcare organizations to provide convenient medication solutions to their members and patients. In 2021, the company announced a merger with Rite Aid Corporation, a leading retail pharmacy chain in the United States, to expand its footprint in the U.S. market.

Overall, Medavail Holdings Inc. is a healthcare technology company that provides convenient and accessible medication solutions through its on-site prescription kiosks and virtual consultations platform. Its partnerships with healthcare organizations and insurers have positioned the company to be a leader in the future of telemedicine and pharmacy services.


   Company Address: 4720 East Cotton Gin Loop, Phoenix, 85040 AZ
   Company Phone Number: 830-0826   Stock Exchange / Ticker: NASDAQ MDVL


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
HCAT   -7.96%    
TDOC   -2.07%    
• View Complete Report
   



Medavail Holdings Inc

Medavail Holdings Inc Struggles with Sharp Revenue Decline and Increased Losses in Q2 2023

Medavail Holdings Inc, a Pharmacy Services & Retail Drugstore company, has recently released its second-quarter financial report for 2023. The results were disappointing, with revenue fading by -96.379% to $0.41 million compared to the same quarter last year. Additionally, the shortfall per share has extended to $-3.06, which is a significant increase from the previous reporting season.
However, despite Medavail Holdings' poor performance, the Pharmacy Services & Retail Drugstore sector as a whole recorded a revenue gain in the second quarter of 2023. This is a positive sign for the industry, but it highlights the struggles that Medavail Holdings is facing.
Medavail Holdings Inc

Medavail Holdings Inc Reports Profound Downturn in Revenue for the Most Recent Fiscal Quarter

The financial results for the first quarter of 2023 for Medavail Holdings Inc are not positive. The company lost $0.16 per share, which is an improvement from the previous year's loss of $0.40 per share, but still represents a deficit. This deficit also grew from the previous reporting period where the loss was only $0.09 per share. Additionally, the revenue for the first quarter of 2023 plummeted by 93.197% to just $0.62 million compared to $9.11 million a year ago. The drop was even more severe sequentially, with revenue tumbling by 94.537% from $11.35 million. Finally, the net deficit for the first quarter of 2023 was even larger than the previous year's, at $-17.330 million compared to $-13.022 million.
These financial results are a cause for concern for Medavail Holdings Inc as they show a significant decline in revenue. The drop in revenue is particularly concerning as it is so severe and is likely to have a ripple effect across other areas of the business. The increasing net deficit is also an indicator that the company is struggling to operate effectively, and the year-over-year loss per share suggests that they are not making progress in improving their financial situation.









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com